Ex vivo activation of naturally occurring IL-17-producing T cells does not require IL-6

Cytokine

Volumn 58, Issue 2, 2012, Pages 231-237

  Smolianov, Vsevolod ^a   Dehmel, Thomas ^a   Kieseier, Bernd C ^a   Hemmer, Bernhard ^b   Hartung, Hans Peter ^a   Hofstetter, Harald H ^a  

^a Department of Orthopedic Surgery   (Germany)

^b TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

Cytokine; EAE; Interleukin 17; T cell; Thymus

Indexed keywords

INTERLEUKIN 17; INTERLEUKIN 2; INTERLEUKIN 6;

ANIMAL CELL; ARTICLE; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; EX VIVO STUDY; IMMUNOREGULATION; MOUSE; NONHUMAN; NT17 CELL; PRIORITY JOURNAL; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; THYMOCYTE;

ANIMALS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; INTERLEUKIN-17; INTERLEUKIN-6; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; T-LYMPHOCYTES; THYMUS GLAND;

EID: 84859211570     PISSN: 10434666     EISSN: 10960023     Source Type: Journal    
DOI: 10.1016/j.cyto.2012.01.010     Document Type: Article

References (44)

1. Aggarwal S., Gurney A.L. IL-17: prototype member of an emerging cytokine family. J Leukoc Biol 2002, 71:1-8.
2. Applequist S.E., Wallin R.P., Ljunggren H.G. Variable expression of Toll-like receptor in murine innate and adaptive immune cell lines. Int Immunol 2002, 14(9):1065-1074.
3. Bendigs S., Salzer U., Lipford G.B., Wagner H., Heeg K. CpG-oligodeoxynucleotides co-stimulate primary T cells in the absence of antigen-presenting cells. Eur J Immunol 1999, 29:1209-1218.
4. Bettelli E., Carrier Y., Gao W., Korn T., Strom T.B., Oukka M., et al. Reciprocal developmental pathways for the generation of pathogenic effector Th17 and regulatory T cells. Nature 2006, 441:235-238.
5. Dong C. Differentiation and function of proinflammatory Th17 cells. Microbes Infect 2009, 11:584-588.
6. Fang C., Zhang X., Miwa T., Song W.C. Complement promotes the development of inflammatory T-helper 17 cells through synergistic interaction with toll-like receptor signaling and interleukin 6 production. Blood 2009, 114:1005-1015.
7. Freitas A., Alves-Filho J.C., Victoni T., Secher T., Lemos H.P., Sonego F., et al. IL-17 receptor signaling is required to control polymicrobial sepsis. J Immunol 2009, 182:7846-7854.
8. Gold R., Lühder F. Interleukin-17 - extended features of a key player in multiple sclerosis. Am J Pathol 2008, 172:8-10.
9. Haak S., Croxford A.L., Kreymborg K., Heppner F.L., Pouly S., Becher B., et al. IL-17A and IL-17F do not contribute vitally to autoimmune neuro-inflammation in mice. J Clin Invest 2008, 119:61-69.
10. Harrington L.E., Hatton R.D., Mangan P.R., Turner H., Murphy T.L., Murphy K.M., et al. Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nat Immunol 2005, 6:1123-1132.
11. Hofstetter H.H., Ibrahim S.M., Koczan D., Kruse N., Weishaupt A., Toyka K.V., et al. Therapeutic efficacy of IL-17 neutralization in murine experimental autoimmune encephalomyelitis. Cell Immunol 2005, 237:123-130.
12. Hofstetter H.H., Toyka K.V., Tary-Lehmann M., Lehmann P.V. Kinetics and organ distribution of IL-17-producing CD4 cells in proteolipid protein 139-151 peptide-induced experimental autoimmune encephalomyelitis of SJL mice. J Immunol 2007, 178:1372-1378.
13. Hofstetter H.H., Lühder F., Toyka K.V., Gold R. IL-17 production by thymocytes upon CD3 stimulation and costimulation with microbial factors. Cytokine 2006, 34:184-197.
14. Hofstetter H., Grau C., Buttmann M., Forsthuber T.G., Gaupp S., Toyka K.V., et al. The PLPp-specific T-cell population promoted by pertussis toxin is characterized by high frequencies of IL-17 producing cells. Cytokine 2007, 40:35-43.
15. Ivanov I.I., McKenzie B.S., Zhou L., Tadokoro C.E., Lepelley A., Lafaille J.J., et al. The orphan nuclear receptor RORgammat directs the differentiation program of proinflammatory IL-17+ T helper cells. Cell 2006, 126:1121-1133.
16. Jensen K.D., Su X., Shin S., Li L., Youssef S., Yamasaki S., et al. Thymic selection determines gamma-delta T cell efector fate: antigen-naive cells make interleukin-17 and antigen-experienced cells make interferon-gamma. Immunity 2008, 29:90-100.
17. Khader S.A., Bell G.K., Pearl J.E., Fountain J.J., Rangel-Moreno J., Cilley G.E., et al. IL-23 and IL-17 in the establishment of protective pulmonary CD4+ T cell responses after vaccination and during Mycobacterium tuberculosis challenge. Nat Immunol 2007, 8:369-377.
18. Kim J.S., Smith-Garvin J.E., Koretzky G.A., Jordan M.S. The requirements for natural Th17 cell development are distinct from those of conventional Th17 cells. J Exp Med 2011, [Epub ahead of print].
19. Komiyama Y., Nakae S., Matsuki T., Nambu A., Ishigame H., Kakuta S., et al. IL-17 plays an important role in the development of experimental autoimmune encephalomyelitis. J Immunol 2006, 177:566-573.
20. Korn T., Bettelli E., Gao W., Awasthi A., Jäger A., Strom T.B., et al. IL-21 initiates an alternative pathway to induce proinflammatory T(H)17 cells. Nature 2007, 448:484-487.
21. Korn T., Oukka M., Bettelli E. Th17 cells: effector T cells with inflammatory properties. Semin Immunol 2007, 19:362-371.
22. Langrish C.L., Chen Y., Blumenschein W.M., Mattson J., Basham B., Sedgwick J.D., et al. IL-23 drives a pathogenic T cell population that induces autoimmune inflammation. J Exp Med 2005, 201:233-240.
23. Laurence A., Tato C.M., Davidson T.S., Kanno Y., Chen Z., Yao Z., et al. Interleukin 2 signaling via STAT5 constrains T helper 17 cell generation. Immunity 2007, 26:371-381.
24. Lubberts E., Koenders M.I., van den Berg W.B. The role of T cell interleukin-17 in conducting destructive arthritis: lessons from animal models. Arthritis Res Ther 2005, 7:29-37.
25. Luger D., Silver P.B., Tang J., Cua D., Chen Z., Iwakura Y., et al. Either a Th17 or a Th1 effector response can drive autoimmunity: conditions of disease induction affect dominant effector category. J Exp Med 2008, 205:799-810.
26. Mannon R.B., Nataraj C., Pisetsky D.S. Stimulation of thymocyte proliferation by phosphorothioate DNA oligonucleotides. Cell Immunol 2000, 201:14-21.
27. Marks B.R., Nowyhed H.N., Choi J.Y., Poholek A.C., Odegard J.M., Flavell R.A., et al. Thymic self-reactivity selects natural interleukin 17-producing T cells that can regulate peripheral inflammation. Nat Immunol 2009, 10:1132.
28. Mars L.T., Araujo L., Kerschen P., Diem S., Bourgeois E., Van L.L.P., et al. Invariant NKT cells inhibit development of the Th17 lineage. Proc Natl Acad Sci USA 2009, 106:6238-6243.
29. Michel M.L., Keller A.C., Paget C., Fujino M., Trottein F., Savage P.B., et al. Identification of an IL-17-producing NK1.1(neg) iNKT cell population involved in airway neutrophilia. J Exp Med 2007, 204:995-1001.
30. Michel M.L., Mendes-da-Cruz D., Keller A.C., Lochner M., Schneider E., Dy M., et al. Critical role of ROR-gammat in a new thymic pathway leading to IL-17-producing invariant NKT cell differentiation. Proc Natl Acad Sci USA 2008, 105:19845-19850.
31. Miljkovic D., Stosic-Grujicic S., Markovic M., Momcilovic M., Ramic Z., Maksimovic-Ivanic D., et al. Strain difference in susceptibility to experimental autoimmune encephalomyelitis between Albino Oxford and Dark Agouti rats correlates with disparity in production of IL-17, but not nitric oxide. J Neurosci Res 2006, 84:379-388.
32. Miyamoto M., Prause O., Sjöstrand M., Laan M., Lötvall J., Linden A. Endogenous IL-17 as a mediator of neutrophil recruitment caused by endotoxin exposure in mouse airways. J Immunol 2003, 170:4665-4672.
33. Nurieva R., Yang X.O., Martinez G., Zhang Y., Panopoulos A.D., Ma L., et al. Essential autocrine regulation by IL-21 in the generation of inflammatory T cells. Nature 2007, 448:480-483.
34. O'Connor W., Kamanaka M., Booth C.J., Town T., Nakae S., Iwakura Y., et al. A protective function for interleukin 17A in T cell-mediated intestinal inflammation. Nat Immunol 2009, 10:603-609.
35. Okada T., Lian Z.X., Naiki M., Ansari A.A., Ikehara S., Gerschwin M.E. Murine thymic plasmacytoid dendritic cells. Eur J Immunol 2003, 33:1012-1019.
36. Park H., Li Z., Yang X.O., Chang S.H., Nurieva R., Wang Y.H., et al. A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17. Nat Immunol 2005, 6:1133-1141.
37. Pernis A.B. Th17 cells in rheumatoid arthritis and systemic lupus erythematosus. J Intern Med 2009, 265:644-652.
38. Rachitskaya A.V., Hansen A.M., Horai R., Li Z., Villasmil R., Luger D., et al. NKT cells constitutively express IL-23 receptor and RORgammat and rapidly produce IL-17 upon receptor ligation in an IL-6-independent fashion. J Immunol 2008, 180:5167-5171.
39. Ribot J.C., deBarros A., Pang D.J., Neves J.F., Peperuzak V., Roberts S.J., et al. CD 27 is a thymic determinant of the balance between interferon-gamma and interleukin-17-producing gamma-delta T cell subsets. Nat Immunol 2009, 10:427-436.
40. Richez C., Yasuda K., Watkins A.A., Akira S., Lafyatis R., van Seventer J.M., et al. TLR4 ligands induce IFN-alpha production by mouse conventional dendritic cells and human monocytes after IFN-beta priming. J Immunol 2009, 182(2):820-828.
41. Roark C.L., Simonian P.L., Fontenot A.P., Born W.K., O'brien R.L. Gamma-delta T cells: an important source of IL-17. Curr Opin Immunol 2008, 20:353-357.
42. Tanaka S., Yoshimoto T., Naka T., Nakae S., Iwakura Y., Cua D., et al. Natural occuring IL-17 producing T cells regulate the initial phase of neutrophil mediated airway responses. J Immunol 2009, 183:7523-7530.
43. Torchinsky M.B., Garaude J., Martin A.P., Blander J.M. Innate immune recognition of infected apoptotic cells directs T(h)17 cell differentiation. Nature 2009, 458:78-82.
44. Van de Veerdonk F.L., Marijnissen R.J., Kullberg B.J., Koenen H.J., Cheng S.C., Joosten I., et al. The macrophage mannose receptor induces IL-17 in response to Candida albicans. Cell Host Microbe 2009, 5:329-340.